Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2008-06-05 (17 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: FONTENAY-SOUS-BOIS (94120), Val-de-Marne
PHARMACIE J F BERTRAND : revenue, balance sheet and financial ratios
PHARMACIE J F BERTRAND is a French company
founded 17 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in FONTENAY-SOUS-BOIS (94120),
this company of category PME
shows in 2022 a revenue of 1.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE J F BERTRAND (SIREN 505359976)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
1 795 492 €
N/C
N/C
1 542 407 €
1 563 999 €
1 396 000 €
1 401 229 €
Net income
36 320 €
36 315 €
105 617 €
133 118 €
71 853 €
50 450 €
45 458 €
37 891 €
51 268 €
EBITDA
N/C
N/C
137 001 €
N/C
N/C
66 601 €
64 764 €
52 022 €
74 620 €
Net margin
N/C
N/C
5.9%
N/C
N/C
3.3%
2.9%
2.7%
3.7%
Revenue and income statement
In 2024, PHARMACIE J F BERTRAND generates positive net income of 36 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 51 k€ -> 36 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
36 320 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 13%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 77%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
13.001%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
76.611%
Solvency indicators evolution PHARMACIE J F BERTRAND
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
84.556
65.726
50.301
36.339
27.93
15.576
6.941
15.135
13.001
Financial autonomy
44.959
47.297
55.63
60.515
63.205
68.069
76.303
71.893
76.611
Repayment capacity
7.245
7.009
4.865
3.822
None
None
0.516
None
None
Cash flow / Revenue
3.363%
2.962%
3.138%
3.167%
None%
None%
5.86%
None%
None%
Sector positioning
Debt ratio
13.02024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent
In 2024, the debt ratio of PHARMACIE J F BERTRAND (13.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
76.61%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent
In 2024, the financial autonomy of PHARMACIE J F BERTRAND (76.6%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.52 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Excellent
In 2022, the repayment capacity of PHARMACIE J F BERTRAND (0.52) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 327.68. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
327.675
Liquidity indicators evolution PHARMACIE J F BERTRAND
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
173.585
151.855
170.459
164.147
178.801
185.942
221.492
266.996
327.675
Interest coverage
9.296
7.933
6.144
4.249
None
None
0.701
None
None
Sector positioning
Liquidity ratio
327.682024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent+18 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE J F BERTRAND (327.68) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
0.7x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Average
In 2022, the interest coverage of PHARMACIE J F BERTRAND (0.7x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE J F BERTRAND
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
179 273 €
232 155 €
196 204 €
208 533 €
0 €
0 €
296 579 €
0 €
0 €
Inventory turnover (days)
31
33
27
28
0
0
29
0
0
Customer payment term (days)
6
11
7
9
0
0
7
0
0
Supplier payment term (days)
34
49
31
32
0
0
39
0
0
Positioning of PHARMACIE J F BERTRAND in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE J F BERTRAND is estimated at
507 054 €
(range 353 104€ - 758 581€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
353k€507k€758k€
507 054 €Range: 353 104€ - 758 581€
NAF 5 année 2024
Valuation method used
Net Income Multiple
36 320 €
×
14.0x
=507 054 €
Range: 353 104€ - 758 582€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE J F BERTRAND with other companies in the same sector:
Frequently asked questions about PHARMACIE J F BERTRAND
What is the revenue of PHARMACIE J F BERTRAND ?
The revenue of PHARMACIE J F BERTRAND in 2022 is 1.8 M€.
Is PHARMACIE J F BERTRAND profitable?
Yes, PHARMACIE J F BERTRAND generated a net profit of 36 k€ in 2024.
Where is the headquarters of PHARMACIE J F BERTRAND ?
The headquarters of PHARMACIE J F BERTRAND is located in FONTENAY-SOUS-BOIS (94120), in the department Val-de-Marne.
Where to find the tax return of PHARMACIE J F BERTRAND ?
The tax return of PHARMACIE J F BERTRAND is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE J F BERTRAND operate?
PHARMACIE J F BERTRAND operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart